"Hospira’s acquisition of the Orchid API facility will support supply continuity of key beta-lactam antibiotic products, improve our cost position and pave the way for future API development,"
Anoro is a once-daily combination treatment comprised of two bronchodilators, umeclidinium (UMEC), a long-acting muscarinic antagonist (LAMA), and vilanterol (VI), a long-acting beta2 agonist (LABA), in a single
Dovobet® Ointment is a topical combination of active vitamin D3 calcipotriol and the corticosteroid betamethasone dipropionate. LEO Pharma K.K. filed an application for approval to the Ministry of
The acquisition includes one product marketed under an Abbreviated New Drug Application (ANDA) – Ursodiol tablet – and one approved ANDA that is not yet marketed – Lamotrigine
The approval is based on data from the Phase III DECISION (stuDy of sorafEnib in loCally advanced or metastatIc patientS with radioactive Iodine refractory thyrOid caNcer) trial. In
"We believe these new development initiatives will further increase the value of Celladon’s pipeline and potentially allow us to broaden the clinical utility of MYDICAR for a wide
Teva submitted this CP according to the FDA’s procedural guidance and in accordance with the Agency’s desire to facilitate public review and comment regarding new scientific data on
NAI had been named as a co-defendant in cases involving a dietary supplement called Jack3d, which contains 1,3-dimethylylamylamine (also known as DMAA), which was formulated, made for and
"LPC has been an important partner over the years and we are pleased to continue our relationship with them. This facility gives us an additional option in funding
Medicure also received an option to acquire all of the remaining issued shares of Apicore LLC and the holding company of Apicore US LLC, within the next 3
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.